CIA
GMAB icon

Cape Investment Advisory’s Genmab GMAB Stock Holding History

Cape Investment Advisory’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21K Buy
+44
New +$1.17K ﹤0.01% 1307
2026
Q1 		– Sell
-44
Closed -$1.35K – 593
2025
Q4 		$1.35K Buy
+44
New +$1.37K ﹤0.01% 1156

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cape Investment Advisory's GMAB Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in Genmab (GMAB) in Q2 2026: 44 shares worth $1.21K. The stake represents ﹤0.01% of the portfolio and ranks #1307 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in GMAB as recently as Q4 2025.

Cape Investment Advisory first reported a position in GMAB in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.35K in Q4 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Cape Investment Advisory held 44 shares of Genmab worth $1.21K as of Q2 2026.
  • Genmab was a new Cape Investment Advisory position in Q2 2026.
  • Genmab made up ﹤0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #1307 holding.
  • Cape Investment Advisory first reported a position in Genmab in Q4 2025 and has held it in 2 quarters since.
  • Cape Investment Advisory's Genmab position peaked at $1.35K in Q4 2025.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.